検索結果
-
世界的成長株 半導体 世界各国の機関投資家やヘッジファンド ための優良情報 NCT unveiling the Gallium Oxide Revolution: Pioneering Sustainable Semiconductor Solutions WebsEdge Science ,300 回視聴 2024/04/22 Join us on a journey into the heart of innovation as we explore the transformative potential of Gallium Oxide in shaping our electrified future. In the era of green transformation, semiconductors emerge as the unsung heroes propelling our modern world forward. Discover how Gallium Oxide, led by Novel Crystal Technology in Japan, promises unparalleled performance and cost efficiency, revolutionizing the landscape of power conversion technology. From its superior efficiency at high voltages to its seamless integration into existing fabrication lines, Gallium Oxide stands poised to disrupt the status quo. Witness the groundbreaking advancements and collaborative efforts driving the Gallium Oxide revolution as we invite you to join us in this thrilling ecosystem of innovation and sustainable progress.
In addition, th…
2024/05/30 10:13
In addition, the results are only generalizable to the sample enrolled, which comprised mainly patients of Caucasian ethnicity, and may not fully account for the known ethnic disparities in disease outcomes in colorectal cancer (28). In conclusion, this randomized phase III trial indicated that arfolitixorin (120 mg/m2) does not have superior efficacy to leucovorin (400 mg/m2) in mCRC, and it is possible that outcomes would be improved with a higher dose. AGENT trialの考察部分ですが,主に白人を中心とした試験であることがlimitationとしてあげられています.アジア人と白人の代謝能は大きく異なっている可能性もあり,大きなlimitationとして考えられます.用量に関しても,十分ではない可能性も論文でもはっきりと言及されています. 今回のSP-05の再検討で結果が出たら,標準治療を大きく塗り替えることになります.今後の結果を楽しみにしています.